These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2418384)

  • 61. CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis.
    Carlborg A; Jokinen J; Nordström AL; Jönsson EG; Nordström P
    Schizophr Res; 2009 Jul; 112(1-3):80-5. PubMed ID: 19410429
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CSF 5HIAA and personal and family history of suicide in affectively ill patients: a negative study.
    Roy-Byrne P; Post RM; Rubinow DR; Linnoila M; Savard R; Davis D
    Psychiatry Res; 1983 Dec; 10(4):263-74. PubMed ID: 6199808
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?
    Asberg M; Träskman L; Thorén P
    Arch Gen Psychiatry; 1976 Oct; 33(10):1193-7. PubMed ID: 971028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical considerations of biological correlates of suicide.
    Motto JA
    Suicide Life Threat Behav; 1986; 16(2):83-102. PubMed ID: 2428143
    [No Abstract]   [Full Text] [Related]  

  • 65. Biological suicide research: outcome and limitations.
    van Praag HM
    Biol Psychiatry; 1986 Nov; 21(13):1305-23. PubMed ID: 2428412
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid.
    Volicer L; Langlais PJ; Matson WR; Mark KA; Gamache PH
    Arch Neurol; 1985 Dec; 42(12):1158-61. PubMed ID: 2415092
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables.
    Brown RP; Stoll PM; Stokes PE; Frances A; Sweeney J; Kocsis JH; Mann JJ
    Psychiatry Res; 1988 Feb; 23(2):167-78. PubMed ID: 3363026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 5-HT and 5-HIAA in cerebrospinal fluid in depression.
    Gjerris A; Sørensen AS; Rafaelsen OJ; Werdelin L; Alling C; Linnoila M
    J Affect Disord; 1987; 12(1):13-22. PubMed ID: 2437171
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neurotic depression: a diagnosis based on preexisting characteristics.
    Winokur G; Black DW; Nasrallah A
    Eur Arch Psychiatry Neurol Sci; 1987; 236(6):343-8. PubMed ID: 3678293
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The serotonin hypothesis of (auto)aggression. Critical appraisal of the evidence.
    Van Praag HM; Plutchik R; Conte H
    Ann N Y Acad Sci; 1986; 487():150-67. PubMed ID: 2436530
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Urinary excretion of 5-hydroxyindoleacetic acid--no relationship to the level in cerebrospinal fluid.
    Bertilsson L; Tybring G; Braithwaite R; Träskman-Bendz L; Asberg M
    Acta Psychiatr Scand; 1982 Sep; 66(3):190-8. PubMed ID: 6182758
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chemoprophylaxis of depressions. An attempt to compare lithium with 5-hydroxytryptophan.
    van Praag HM; de Haan S
    Acta Psychiatr Scand Suppl; 1981; 290():191-201. PubMed ID: 6164250
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.
    Ciaranello RD; Anders TF; Barchas JD; Berger PA; Cann HM
    Child Psychiatry Hum Dev; 1976; 7(2):127-33. PubMed ID: 1088261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness.
    Mendlewicz J; Youdim MB
    J Affect Disord; 1980 Jun; 2(2):137-46. PubMed ID: 6448885
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CSF somatostatin in affective illness.
    Rubinow DR; Gold PW; Post RM; Ballenger JC; Cowdry R; Bollinger J; Reichlin S
    Arch Gen Psychiatry; 1983 Apr; 40(4):409-12. PubMed ID: 6132592
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Depression vulnerability and 5-hydroxytryptophan prophylaxis.
    van Praag H; de Hann S
    Psychiatry Res; 1980 Sep; 3(1):75-83. PubMed ID: 6160599
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Depression, violent suicide tied to low metabolite level.
    Ziporyn T
    JAMA; 1983 Dec; 250(23):3141-2. PubMed ID: 6196495
    [No Abstract]   [Full Text] [Related]  

  • 78. l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions.
    van Hiele LJ
    Neuropsychobiology; 1980; 6(4):230-40. PubMed ID: 6967194
    [No Abstract]   [Full Text] [Related]  

  • 79. Hypothalamic-pituitary-adrenal axis and suicide.
    Arató M; Banki CM; Nemeroff CB; Bissette G
    Ann N Y Acad Sci; 1986; 487():263-70. PubMed ID: 3032060
    [No Abstract]   [Full Text] [Related]  

  • 80. Depression, suicide and the metabolism of serotonin in the brain.
    Van Praag HM
    J Affect Disord; 1982 Dec; 4(4):275-90. PubMed ID: 6186712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.